B

Biogen

Develops therapies for neurological disorders

Head of Regulatory CMC - Biologics & Advanced Therapy Medicinal Products

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeCambridge, MA, USA

About the Job

Requirements

  • An advanced degree or Ph.D. in Life Sciences, Pharmacy, Medicines, or a related discipline.
  • At least 15 years of experience within regulatory agencies or the pharmaceutical industry.
  • Significant leadership experience in Regulatory Sciences.
  • A proven track record of successful global regulatory submissions and approvals for biologics and/or advanced therapy medicinal products.
  • Significant understanding of international regulations and policy-setting processes of major regulatory agencies.
  • Active engagement in major industry associations, conferences, and forums.
  • Experience collaborating and negotiating with cross-functional teams.
  • Experience working across global development and manufacturing networks, including external partners.

Responsibilities

  • Lead the CMC regulatory team in developing and executing global CMC regulatory strategies for biologics and advanced therapy medicinal products.
  • Assess regulatory risks and develop mitigation approaches to support timely product approvals.
  • Ensure submission readiness and regulatory compliance across all phases of development and commercialization.
  • Guide global interactions with Health Authorities on CMC topics, including preparing briefing materials and responses to agency questions.
  • Oversee post-approval lifecycle activities and evaluate manufacturing and analytical changes for regulatory submissions.
  • Represent the regulatory function in evaluating new product opportunities and coordinate with Technical Operations, Quality, and Supply Chain.
  • Participate in external industry meetings and forums, organize discussions, and deliver presentations.
  • Provide recommendations and risk assessments to influence decisions in governance forums.
  • Review and approve regulatory submissions to ensure alignment with global requirements and business timelines.

About the Company

Biogen

Develops therapies for neurological disorders

Biogen is a global biotechnology company focused on neuroscience. It discovers, develops, and delivers therapies for neurological disorders, such as multiple sclerosis and other neurodegenerative diseases. Its product process starts with research and development to identify potential drugs, followed by clinical testing and regulatory approval, ultimately leading to commercialization and patient treatment. Biogen differentiates itself through a long history (founded in 1978), a deep specialization in neuroscience, and an integrated pipeline that moves ideas from discovery to approved medicines, aiming to create value for shareholders while helping communities. The company’s goal is to advance therapies for neurological diseases to improve patients’ lives and generate sustainable value for stakeholders.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
1978

Recently Posted Jobs

Explore more opportunities at Biogen

See more jobs